OSR Health (OSRHW) Acquisitions (2025 - 2026)
OSR Health (OSRHW) posted Acquisitions of -$10754.7 for Q1 2026, down 231.56% sequentially from $8175.0 in Q4 2025, and up 99.1% YoY from -$5401.6 in Q1 2025.
OSR Health (OSRHW) Acquisitions (2025 - 2026) Analysis & Trends
OSR Health has reported Acquisitions for 2 years, with the latest figure at -$10754.7 in Q1 2026.
- Quarterly Acquisitions rose 99.1% year-over-year to -$10754.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36419.9 (changed N/A YoY) and the FY2025 annual result came in at -$1.2 million, changed N/A from the prior year.
- Acquisitions declined to -$10754.7 in Q1 2026 per OSRHW's latest filing, from $8175.0 in the prior quarter.
- Over five years, Acquisitions peaked at $8175.0 in Q4 2025 and troughed at -$1.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | - |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | - |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 135.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,754.71 |
| Dec 31, 2025 | 8,175.00 |
| Sep 30, 2025 | -13,081.00 |
| Jun 30, 2025 | -20,759.20 |
| Mar 31, 2025 | -1.20 Mn |